<img alt="" src="https://secure.intelligentdatawisdom.com/783761.png" style="display:none;">

Makevale makes multi-million pound investment in production facilities

Makevale, the global leaders in high-performance polymers, can announce it will be making a multi-million pound investment in its production facilities this year.

The company (Makevale Group) can also announce it has delivered stronger than expected provisional financial results for 2020. This performance and continued, steady growth has meant the investment decisions have been accelerated to cater for an increase in demand across the Group’s portfolio of products across a range of markets and verticals.

These expansion projects are expected to boost production capability by as much as 40% upon completion. This expansion will enable the group to continue its growth and service the growing demand from existing customers, as well as new ones in new markets.

Commenting on the announcement, Dr. Samit Ahir (Makevale Group CEO) said:

“We’ve made this decision as the Group has continued to grow well, even during this time of turbulence and volatility in the wider market. We owe a lot to the great businesses we work with, as we’ve continued to see strong demand despite the circumstances. We have also made significant progress in entering new markets, with some extremely exciting opportunities for the group beginning to convert into tangible business.”

The projects will ensure Makevale can continue to provide the highest quality materials and service to its existing customers while creating capacity for new customers in new markets.

The three projects will see the group open a brand new, purpose-built facility in Blackpool, UK. This facility has been designed to exceed the ISO requirements for medical device manufacturing, ensuring all customers benefit from the highest manufacturing standards.

Elsewhere, Makevale’s facility in India, currently the largest, will also be expanded. This is in response to growth in markets such as Asia and Australia, where the growing biomedical technology markets are generating new opportunities for growth.

Dr. Samit Ahir continues:

“This past year has been career-defining whether you are operating the factory floor, working for a team from an office or a home, or just trying to lead talented people. Now is the perfect time to fast track our expansion projects. As well as expanding our facilities, we’re going to bolster our technical talent to ensure our customers can benefit from the latest advancements in chemistry, as well as accessing a steady, dependable supply of materials. It’s the next, all-important step in the Group’s growth plan.”

The Group’s factory at its headquarters in Ware, UK, is also set to expand production capacity.